End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported
Author(s) -
Eric French,
Jeremy McCauley,
María José Aragón,
Pieter Bakx,
Martin Chalkley,
Stacey H. Chen,
Bent Jesper Christensen,
Hongwei Chuang,
Aurélie CôtéSergent,
Mariacristina De Nardi,
Elliott Fan,
Damien Échevin,
PierreYves Geoffard,
Christelle GastaldiMénager,
Mette Gørtz,
Yoko Ibuka,
J. B. Jones,
Malene KallestrupLamb,
Martin Karlsson,
Tobias J. Klein,
Grégoire de Lagasnerie,
PierreCarl Michaud,
Owen O’Donnell,
Nigel Rice,
Jonathan Skinner,
Eddy van Doorslaer,
Nicolas R. Ziebarth,
Elaine Kelly
Publication year - 2017
Publication title -
health affairs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.837
H-Index - 178
eISSN - 2694-233X
pISSN - 0278-2715
DOI - 10.1377/hlthaff.2017.0174
Subject(s) - health spending , demographic economics , public spending , medical care , consumer spending , demography , health care , economics , gerontology , business , medicine , economic growth , political science , family medicine , sociology , health insurance , recession , politics , law , keynesian economics
Although end-of-life medical spending is often viewed as a major component of aggregate medical expenditure, accurate measures of this type of medical spending are scarce. We used detailed health care data for the period 2009-11 from Denmark, England, France, Germany, Japan, the Netherlands, Taiwan, the United States, and the Canadian province of Quebec to measure the composition and magnitude of medical spending in the three years before death. In all nine countries, medical spending at the end of life was high relative to spending at other ages. Spending during the last twelve months of life made up a modest share of aggregate spending, ranging from 8.5 percent in the United States to 11.2 percent in Taiwan, but spending in the last three calendar years of life reached 24.5 percent in Taiwan. This suggests that high aggregate medical spending is due not to last-ditch efforts to save lives but to spending on people with chronic conditions, which are associated with shorter life expectancies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom